Nyxthracis (previously Obiltoxaximab SFL) Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - Ónæmiskerfið sera og mótefni, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Lamisil Krem 10 mg/g Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

lamisil krem 10 mg/g

karo healthcare ab - terbinafinum hýdróklóríð - krem - 10 mg/g

Metylfenidat Actavis Forðatafla 18 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metylfenidat actavis forðatafla 18 mg

actavis group ptc ehf. - methylphenidatum hýdróklóríð - forðatafla - 18 mg

Serevent Innúðalyf, dreifa 25 míkróg/skammt Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

serevent innúðalyf, dreifa 25 míkróg/skammt

glaxosmithkline pharma a/s - salmeterolum xínafóat - innúðalyf, dreifa - 25 míkróg/skammt

Terbinafin Actavis Tafla 250 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

terbinafin actavis tafla 250 mg

actavis group ptc ehf. - terbinafinum hýdróklóríð - tafla - 250 mg

Bactroban Smyrsli 20 mg/g Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

bactroban smyrsli 20 mg/g

glaxosmithkline pharma a/s - mupirocinum inn - smyrsli - 20 mg/g

Bactroban Nasal Nefsmyrsli 20 mg/g Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

bactroban nasal nefsmyrsli 20 mg/g

glaxosmithkline pharma a/s - mupirocinum kalsíum - nefsmyrsli - 20 mg/g